Cargando…
Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes
BACKGROUND: The in vitro production of mature human red blood cells (RBCs) from induced pluripotent stem cells (iPSCs) has been the focus of research to meet the high demand for blood transfusions. However, limitations like high costs and technological requirements restrict the use of RBCs produced...
Autores principales: | Park, Yu Jin, Jeon, Su-Hee, Kim, Hyun-Kyung, Suh, Eun Jung, Choi, Seung Jun, Kim, Sinyoung, Kim, Hyun Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291485/ https://www.ncbi.nlm.nih.gov/pubmed/32532292 http://dx.doi.org/10.1186/s12967-020-02403-y |
Ejemplares similares
-
In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources
por: Cho, Youn Keong, et al.
Publicado: (2023) -
Erythroid Differentiation of Induced Pluripotent Stem Cells Co-cultured with OP9 Cells for Diagnostic Purposes
por: Roh, Juhye, et al.
Publicado: (2022) -
Human Endometrium Derived Induced Pluripotent Stem Cells Are Amenable to Directed Erythroid Differentiation
por: Kim, Hyun Kyung, et al.
Publicado: (2023) -
Erythropoietic Potential of CD34+ Hematopoietic Stem Cells from Human Cord Blood and G-CSF-Mobilized Peripheral Blood
por: Jin, Honglian, et al.
Publicado: (2014) -
Blood Supply and Demand in Korea: What is in Store for the Future?
por: Roh, Juhye, et al.
Publicado: (2020)